Abeona Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $400 | $0 | $4,782 | $0 |
Gross Profit | 300 | -815 | 2,391 | -722 |
EBITDA | 126,070 | -10,216 | -7,435 | -28,445 |
EBIT | 125,302 | -11,031 | -8,211 | -29,167 |
Net Income | 108,833 | -12,029 | -9,293 | -30,269 |
Net Change In Cash | 400 | 0 | 4,782 | 0 |
Free Cash Flow | -21,685 | -19,803 | -17,165 | -12,638 |
Cash | 163,535 | 15,936 | 23,357 | 15,726 |
Basic Shares | 66,640 | 49,779 | 41,048 | 48,082 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $3,500 | $1,414 | $3,000 |
Gross Profit | -2,907 | 1,895 | 964 | -1,464 |
EBITDA | -56,619 | -50,572 | -34,383 | -76,802 |
EBIT | -59,526 | -53,770 | -38,960 | -81,266 |
Net Income | -63,734 | -54,188 | -39,696 | -84,936 |
Net Change In Cash | 0 | 3,500 | 1,414 | 3,000 |
Free Cash Flow | -58,461 | -37,340 | -43,613 | -69,816 |
Cash | 23,357 | 14,473 | 14,217 | 32,938 |
Basic Shares | 41,048 | 21,380 | 7,862 | 3,938 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $1.71 |
2025-03-31 | -$0.24 |
2024-12-31 | -$0.31 |
